Preliminary report of an epidemic tularemia outbreak in Valladolid;Descripción preliminar de un brote epidémico de tularemia en Valladolid

Revista Clinica Espanola

Volumn 198, Issue 12, 1998, Pages 789-793

  Bachiller Luque, P ^a,b   Perez Castrillon J L ^a   Martin Luquero M ^a   Mena Martin F J ^a   De La Lama Lopez Areal J ^a   Perez Pascual P ^a   Mazon M A ^a   Herreros Guilarte, V ^a  

^a HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

^b NONE   (Spain)

Author keywords

Epidemic outbreak; Francisella tularensis; Tularemia

Indexed keywords

ADULT; ARTICLE; EPIDEMIC; FEMALE; HUMAN; MALE; MIDDLE AGED; SEROLOGY; SPAIN; TULAREMIA;

ADULT; DISEASE OUTBREAKS; FEMALE; HUMANS; MALE; MIDDLE AGED; SEROLOGIC TESTS; SPAIN; TULAREMIA;

EID: 0032241181     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Eigelsbach HT, McGann VG. Genus Francisella Doroféev 1947, 176al. En: Krieg NR, Holt JG, eds. Bergey's manual of sistematic bacteriology. Baltimore: Williams and Wilkins, 1984; 394-399.
2. McCoy GW. A plague-like disease of rodents. Pub Health Bull 1911; 43:53-71.
3. McCoy GW, Chapin CW. Bacterium tularense, the cause of a plaguelike disease of rodents. Pub Health Bull 1912; 53:17-23.
4. McCoy GW, Chapin CW. Further observations on a plaguelike disease of rodents with a preliminary note on the causative agent Bacterium tularense. J Infect Dis 1912; 10:61-72.
5. Francis E. Tularemia. JAMA 1925; 84:1.243-1.250.
6. Vail DT. Bacterium tularense infection of the eye. Ophtalmol Rec 1914; 23:487.
7. Wherry WB, Lamb BH. Infection of a man with Bacterium tularense. J Infect Dis 1914; 15:331-340.
8. Wherry WB, Lamb BH. Discovery of Bacterium tularense in wild rabbits and the dangers of its transmission to man. JAMA 1914; 63:2.041.
9. Jellison WL. Tularemia: Dr Edward Francis and his first 23 isolates of Francisella tularensis. Bull Hist Med 1972; 46:477-485.
10. Centro Nacional de Epidemiología, Instituto de Salud Carlos III. Brote de tularemia en Castilla y Léon. Bol Epidemiol Semanal 1997; 5:249-251 (impreso 20 de abril de 1998).
11. a ed). Nueva York: Churchill Livingstone Inc., 1995; 2.308-2.317.
12. Enderlin G, Morales L, Jacobs RF, Cross JT. Streptomicyn and alternative agents for the treatment of tularemia: review of the literature. Clin Infect Dis 1994; 19:42-47.
13. Baker CN, Hollis DG, Thornsberry C. Antimicrobial susceptibility testing of Francisella tularensis with a modificated Mueller-Hinton broth. J Clin Microbiol 1985; 22:212-215.
14. Mason WL, Eigelsbach HT, Little SF, et al. Treatment of tularemia, including pulmonary tularemia, with gentamicin. Am Rev Resp Dis 1980; 121:39-45.
15. Arenas R. Tularemia. Estudio de un caso ulceroglandular. Rev Semin Cátedra Patol Med A Barc 1981; 14:397-400.
16. TH International Congress for Infective Disease. Praga, abril, 1994; Abstra 660.
17. Chiristenson B. An outbreak of tularemia in the northerm part of central Sweden. Scand J Infect Dis 1984; 16:285-290.
18. Quan SF, McManus AG, von Fintel H. Infectivity of tularemia applied to intact skin and ingest drinking water. Science 1956; 123:942-943.
19. Centers for Disease Control and Prevention. Tularemia associated with domestic cats-Georgia, New Mexico. MMWR 1982; 31:39-41.
20. Young LS, Bicknell DS, Archer BG, et al. Tularemia epidemic: Vermont, 1968. Forty-seven cases linked to contact with muskrast. N Engl J Med 1969; 280:1.253-1.260.
21. Maranan MC, Schiff D, Johnson DC, Abrahams C, Wylam M, Gerber SI. Pneumonic tularemia in a patient with chronic granulomatous disease. Clin Infect Dis 1997; 25:630-633.
22. Centers for Disease Control and Prevention. Tularemic pneumonia Tennessee. MMWR 1983; 32:262-269.
23. Pettersson T, Nyberg P, Nordström D, Riska H. Similar pleural fluid findings in pleuropulmonary tularemia and tuberculous pleurisy. Chest 1996; 109:572-575.
24. Gill V, Cunha BA. Tularemia pneumonia. Sem Resp Infect 1997; 12:61-67.
25. Teustsch SM, Martone WJ, Brink EW, et al. Pneumonic tularemia on Martha's Vineyard. N Engl J Med 1979; 301:826-828.
26. Syrjala H, Kujala P, Myllylä, et al. Airbone transmission of tularemia in farmers. Scand J Infect Dis 1985; 17:371-375.
27. Francis E. A summary of the present knowledge of tularemia. Medicine 1928; 7:411-432.
28. Greco D, Allegrini G, Tzzi T, et al. A waterborne tularemia outbreak. Eur J Epidemiol 1987; 3:35-38.
29. Steward SJ. Francisella. En: Balows A, Hausler WJ Jr, Hermann KL, et al, eds. Manual of Clinical Microbiology. Washington, DC: American Society for Microbiology, 1991; 454-456.
30. Uhari M, Syrjalä H, Salminen A. Tularemia in children caused by Francisella tularensis biovar palearctica. Pediatr Infect Dis J 1990; 9:80-83.
31. Centers for Disease Control and Prevention. Outbreak of tickborne tularemia-South Dakota. MMWR 1984; 33:601-602.
32. Evans ME, Gregory DW, Schaffner W, McGee ZA. Tularemia: a 30-years experience with 88 cases. Medicine 1985; 64:251-269.
33. Syjälä H, Karvonen J, Salminen A. Skin manifestations of tularemia: a study of 88 cases in Northern Finland during 16 years (1967-1983) Acta Derm Venereol 1984; 64:513-516.
34. Tärnvik A, Sandström G, Sjöstedt A. Infrequent manifestation of tularaemia in Sweden. Scand J Infect Dis 1997; 29:443-446.
35. Daugherty MP, Dolter J, Evans GC, et al. Tularemia. En: Isenberg HD, ed. Clinical microbiology procedures handbook. Washington, DC: American Society for Microbiology, 1992; 1.18.36-1.18.37.
36. Koneman EW, Allen SD, Janda WM, et al. Miscellaneous fastidious gramnegative bacilli. En: Koneman EW, Allen SD, Janda WM, et al, eds. Color atlas and textbook of diagnostic microbiology. Philadelphia: JB Lippincott, 1992; 338-349.
37. Payne MP, Morton RJ. Effect of culture media and incubation temperature on growth of selected strains of Francisella tularensis. J Vet Diagn Invest 1990; 4:264-269.
38. Koskela P, Salminen A. Humoral immunity agains Francisella tularensis after natural infection. J Clin Microbiol 1985; 22:973-979.
39. Tärnvik A. Nature of protective immunity to Francisella tularensis. Rev Infect Dis 1989; 11:440-450.
40. Ericsson M, Sandström G, Sjöstedt A, Tärnvik A. Persistence of cell-mediated immunity and decline of humoral immunity to the intracellular bacterium Francisella tularensis 25 years after natural infection. J Infect Dis 1994; 170:110-114.
41. Sjöstedt A, Eriksson U, Berglund L, Tärnvik A. Detection of Francisella tularensis in ulcers of patients with tularemia by PCR. J Clin Microbiol 1997; 35:1.045-1.048.
42. Long GY, Oprandy JJ, Narayanan RB, Fortier AH, Porter KR, Nacy CA. Detection of Francisella tularensis in blood by polymerase chain reaction. J Clin Microbiol 1993; 31:152-154.
43. Penn RL, Kinasewitz GT. Factors associated with a poor clinical outcome in tularemia. Arch Intern Med 1987; 147:265-268.
44. Risi GF, Pombo DJ. Relapse of tularemia after aminoglycoside threrapy: case report and discussion of threrapeutic options. Clin Infect Dis 1995; 20:174-175.
45. Scheel O, Hoel T, Sandvik T, Berdal B. Susceptibility pattern of Scandinavian Francisella tularensis isolates with regard to oral and parenteral antimicrobial agents. APMIS 1993; 101:33-36.
46. Syrjälä H, Schildt R, Räisäinen S. In vitro susceptibility of Francisella tularensis to fluorquinolones and treatment of tularemia with norfloxacin and ciprofloxacin. Eur J Clin Microbiol Infect Dis 1991; 10: 68-70.
47. Scheel O, Reiersen R, Hoel T. Treatment of tularemia with ciprofloxacin. Eur J Clin Microbiol Infect Dis 1992; 11:447-448.
48. Taylor JP, Istre GR, McChesney TC, et al. Epidemiologic characteristics of human tularemia in the southwest-central states, 1981-1987. Am J Epidemiol 1991; 133:1.032-1.038.
49. Kostman JR, DiNubile MJ. Nodular lymphangitis: a distinctive but often unrecognized syndrome. Ann Intern Med 1993; 118:883-888.